The HCPLive Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.
April 22nd 2024
Prolonged modified fasting, in a multimodal medical approach, may help patients with fibromyalgia improve pain and psychosomatic symptoms.
"REEL" Time Patient Counseling™: Integrating Biosimilars into the Clinical Conversation
View More
Cases and Conversations™: Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis
November 2024
Register Now!
EGPA: Highlighting the Patient Journey to Improve the Differential Diagnosis and Accelerate the Initiation of Guideline-Based Care
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical Consultations™: Optimal Approaches to Recognizing and Treating ANCA-Associated Vasculitis
View More
Knowing "How" and "Why" to Quit Leads to Smoking Cessation
March 11th 2019A new study published online ahead of print in Arthritis Care & Research sheds light on the barriers rheumatology patients face with regards to smoking cessation while describing individual reactions to cessation protocols and identifying patient centered outcomes after improvements in care.
More Competition Fails to Keep Drug Prices Down
March 11th 2019Increased competition in the pharmaceutical market does not necessarily translate into price reductions. "Our findings illustrate a market failure contributing to the rising costs of prescription drugs," researchers write in JAMA Internal Medicine.
Vitamin D Supplementation During Pregnancy Makes Stronger Bones in Babies
March 11th 2019Enhancing supplementation of vitamin D among pregnant women could have far-reaching implications on the bone health of whole societies. That was the conclusion drawn from a study conducted in Iran on the impact of low-dose vitamin D supplements on fetal bone development.
A Case For Omega-3 FA Consumption to Prevent RA
March 11th 2019The impact of omega-3 fatty acids (FA) on systemic inflammatory responses has been demonstrated in a number of dietary and epidemiologic studies. A recent editorial in Joint Bone Spine by Olfa Saidane1 and colleagues suggests a prophylactic role of Omega-3 FAs in the possible prevention of inflammatory diseases such as rheumatoid arthritis (RA).
Frailty Index that Measures Disease in Lupus
March 8th 2019Using a frailty index to predict adverse outcomes and mortality in systemic lupus erythematosus proves to be feasible and effective in a study. The test, SLICC-FI, correlated well with existing measures of SLE disease activity, organ damage and HRQoL.
Trials for Early Onset JIA Treatment Show Promise
March 4th 2019Historically, treatments for children with systemic juvenile idiopathic arthritis (sJIA) have been difficult and ineffective, leading to poor outcomes. But, findings from a new study point to a method that could lead to more positive results.
How long does a hip replacement last?
February 15th 2019Total hip replacements are one of the most common and effective surgeries for women and men with osteoarthritis. The surgery can work miracles in patients, but the technology behind the surgery is not indestructible. At what point does failure set in?
Study Upends Pro Fish Consumption Theory in Rheumatoid Arthritis
February 12th 2019Despite years of research that show omega-3 fatty acids from specific fish species can improve rheumatoid arthritis (RA) symptoms and even protect at-risk patients from developing RA, a new study of 3,863,909 person-years published in BMC Musculoskeletal Disorders finds no benefit.
Calprotectin Test Predicts Relapse in RA and PsA
February 12th 2019Calprotectin is a known marker of disease activity in rheumatoid arthritis (RA) and psoriatic arthritis (PsA). Now, researchers reporting in Arthritis Research and Therapy say that baseline calprotectin levels may predict disease relapse for RA and PsA patients on TNFi therapy. Learn more in this slideshow.